UCMOK
XBI icon

United Capital Management of KS’s SPDR S&P Biotech ETF XBI Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$15.3M Buy
184,347
+5,110
+3% +$424K 2.4% 11
2025
Q1
$14.5M Buy
179,237
+6,122
+4% +$496K 3% 8
2024
Q4
$15.6M Buy
173,115
+2,588
+2% +$233K 2.84% 8
2024
Q3
$16.8M Buy
170,527
+33,044
+24% +$3.26M 3.66% 5
2024
Q2
$12.7M Buy
137,483
+5,245
+4% +$486K 2.81% 12
2024
Q1
$12.5M Buy
132,238
+28,190
+27% +$2.67M 2.87% 11
2023
Q4
$9.29M Buy
104,048
+1,831
+2% +$163K 2.81% 8
2023
Q3
$7.46M Buy
102,217
+2,081
+2% +$152K 2.54% 10
2023
Q2
$8.33M Buy
100,136
+9,593
+11% +$798K 2.67% 8
2023
Q1
$6.9M Buy
90,543
+1,578
+2% +$120K 2.57% 7
2022
Q4
$7.38M Buy
88,965
+18,344
+26% +$1.52M 3.05% 6
2022
Q3
$5.6M Buy
70,621
+764
+1% +$60.6K 2.62% 7
2022
Q2
$5.19M Buy
69,857
+661
+1% +$49.1K 2.44% 7
2022
Q1
$6.22M Buy
69,196
+33,888
+96% +$3.05M 2.41% 10
2021
Q4
$3.95M Buy
35,308
+3,839
+12% +$430K 1.48% 29
2021
Q3
$3.96M Buy
31,469
+2,577
+9% +$324K 1.62% 24
2021
Q2
$3.91M Buy
28,892
+1,840
+7% +$249K 1.6% 23
2021
Q1
$3.67M Buy
27,052
+1,271
+5% +$172K 1.69% 21
2020
Q4
$3.63M Buy
25,781
+1,222
+5% +$172K 1.66% 20
2020
Q3
$2.74M Buy
24,559
+2,038
+9% +$227K 1.43% 27
2020
Q2
$2.52M Sell
22,521
-290
-1% -$32.5K 1.47% 25
2020
Q1
$1.77M Buy
22,811
+3,545
+18% +$274K 1.49% 28
2019
Q4
$1.83M Buy
19,266
+1,735
+10% +$165K 1.16% 31
2019
Q3
$1.34M Buy
17,531
+1,339
+8% +$103K 0.98% 37
2019
Q2
$1.43M Buy
16,192
+813
+5% +$71.8K 1.08% 32
2019
Q1
$1.32M Buy
15,379
+1,329
+9% +$114K 1.03% 33
2018
Q4
$1.01M Buy
14,050
+239
+2% +$17.1K 0.94% 40
2018
Q3
$1.32M Buy
+13,811
New +$1.32M 1.06% 30